Testing how glucose and fat affect blood vessels in healthy adults
Studies whether sugar and fat infusions change blood vessels in lean healthy adults.
Key facts
- Who runs it
- University of Kansas Medical Center
- Where
- Kansas City, United StatesSee the site
- Trial code
- Registry title
- Reversing Glucose and Lipid-mediated Vascular Dysfunction
- Status
- Recruiting
- Phase
- Early phase 1
- People taking part
- 46 people, planned
- Started
- 9 May 2022
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Dextrose 20 % in 500 ML Injection
- Intralipid
- Saline
- Ascorbic acid
- Record updated
- 5 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for lean, healthy adults with normal insulin sensitivity and normal blood pressure. It studies how glucose and fat affect blood vessels and blood pressure.
- Age
- 18 to 79 years
- Sex
- All sexes can join
- Disease stage
- No disease. The trial is looking for lean adults (BMI < 25 kg/m) with normal insulin sensitivity and blood pressure below 140 (systolic) and below 90 mmHg (diastolic).
- Earlier treatment
- Weight stable (+/- 5 lbs (2 kg)) for the previous 3 months. People must be willing to stop vitamin C or E supplements or omega-3 fatty acids starting 2 weeks before.
- Biomarker or test result
- Normal insulin sensitivity, calculated from fasting glucose and insulin levels in the blood.
Main reasons for not taking part
- Type I or Type II diabetes mellitus
- Current smoker or smoking in the past 3 months
- Hyperlipidemia
- Hypertension (>130/80 mmHg)
- History of heart disease or vascular disease
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Lean: BMI < 25 kg/m
- Normal insulin sensitivity: (calculation based on fasting glucose and insulin concentrations in blood)
- Middle-aged: 18-79 years
- Blood pressure: < 140 (systolic) and < 90 mmHg (diastolic
- Weight stable (+/- 5 lbs) for the previous 3 months
- Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior
- Able and willing to provide written informed consent
Who cannot take part
- Current smoker or History of smoking in the past 3 months
- Hypertension: >130/80 mmHg
- History of heart disease (e.g., myocardial infarction, stent, heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy)
- History of vascular disease (e.g., bypass, stroke)
- Diabetes mellitus Type I or Type II: fasting glucose < 126 mg/dL and/or HbA1c < 6.5%
- Hyperlipidemia: Fasting triglycerides < 250 mg/dL
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 79 years old?
Where in United States
- University of Kansas Medical CenterKansas City, United StatesContact: Seth W. W HolwerdaTaking people
About the trial
What the trial wants to find out
The purpose of our study is to understand the extent to which the blood vessels are affected by glucose and fat (lipids) in lean healthy adults and if these changes in the blood vessels contribute to the development of high blood pressure.
The 2 groups in the trial
- Glucose InfusionTreatment being tested
Hyperglycemia (glucose infusion) will receive an I.V. Glucose infusion with a co-infusion of ascorbic acid or placebo at your visit 2 and the alternative treatment of ascorbic acid or placebo will be given on the subsequent study visit 3.
Treatment: Dextrose 20 % in 500 ML Injection, Saline, and Ascorbic acid
- Lipid InfusionTreatment being tested
Hyperlipidemia (lipid infusion) will receive an I.V. Lipid infusion with a co-infusion of ascorbic acid or placebo at your visit 2 and the alternative treatment of ascorbic acid or placebo will be given on the subsequent study visit 3.
Treatment: Intralipid, Saline, and Ascorbic acid
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Reversing Glucose and Lipid-mediated Vascular Dysfunction (REGAL)
- Plain-language title
- Testing how glucose and fat affect blood vessels in healthy adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04832009, who can take part
- Record updated
- 5 June 2025